Assessment of IVD modalities in the indian market.
The Objective of the Study
A global leader in healthcare consulting wanted to understand the current In-Vitro diagnostics market in India particularly focusing on the decision-making process, vendor selection criteria and unmet needs for IVD modalities. A major segment of the research was to understand the buying decision making process that is focussed upon by the healthcare facilities with regards to IVD modalities.
Key Screening Points
- Experts having more than 5 years of relevant experience in the IVD sector were onboarded.
- The facilities targeted were corporate hospitals, public hospitals, corporate/chain laboratories or stand-alone laboratories.
- The shortlisted participants were involved in the usageClinical Chemistry (CC), Immunoassay (IA)&Hematology (Hemat) modalities.
- Organizations having a monthly consumption of reagents for IA, CC and hemat of more than 25 lacs per month were targeted.